Majidova N, Yaslıkaya S, Mıldanoglu MM, Coskun A, Ercan Uzundal D, Sahin TK, et al. Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG). Turkish Journal of Gastroenterology [Internet]. 2025 Apr. 7 [cited 2026 Jan. 1];36(5):293-301. Available from: https://www.turkjgastroenterol.org/index.php/tjg/article/view/4236